Demonstrates that dilated cardiomyopathy secondary to pulmonary tuberculosis can improve with appropriate antitubercular and decongestive therapy.
May warrant TB screening in unexplained DCM; hypothesis-generating and requires prospective confirmation before practice change.
Tuberculosis remains one of the most important cause of preventable mortality and morbidity worldwide. Cardiovascular involvement in tuberculosis, though relatively rare, can be hemodynamically life threatening if not identified or diagnosed appropriately. Here we are reporting a case of sputum positive pulmonary tuberculosis with dilated cardiomyopathy which improved after administration of antitubercular drug along with decongestive therapy.
No takes yet. Share an insight, caveat, or question.
Barman et al. (2015) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: